home2023-05-10T10:55:26+02:00

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

TAmiRNA - stability for live

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

TAmiRNA - stability for live

our focus:
age-associated
diseases

age_associated_diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

TAmiRNA - stability for live

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TamiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

our focus:
age-associated
diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs in any biological matrix.

TAmiRNA - the power of microRNA biomarkers

Kit services

Send us your samples to obtain results for osteomiR®, thrombomiR® or toxomiR® biomarkers by taking advantage of our in-house services.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs.

TAmiRNA - the power of microRNA biomarkers

One-Stop-Shop

Obtain results for osteomiR, thrombomiR,and toxomiR biomarkers in your samples by taking advantage of our inhouseservices.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

latest news

Eager to lern more about Sepsis-associated acute kidney injury?

By |April 10th, 2024|Categories: biomarker, biomarkers, microRNA services, microRNAs, microstructure, miND spike ins, NGS, sequencing, smallRNA, Vivomicx|Tags: , , , |

We are pleased to share our latest publication, a collaborative effort with TAmiRNA, titled 'Sepsis-Induced Heterogeneous Transcription of Coagulation- and Inflammation-Associated Genes in Renal Microvasculature,' which has been published [...]

Exciting news!

By |April 4th, 2024|Categories: biomarker, biomarkers, Illumina NewSeq2000, microRNA services, microRNAs, miND spike ins, NGS, sequencing, smallRNA|Tags: , , , , , , |

We just received the Illumina NextSeq 2000 machine, marking a significant milestone in our journey towards cutting-edge research and innovation. This powerful instrument will drive our NGS services and [...]

TAmiRNA at RNA Leaders conference in Basel

By |March 5th, 2024|Categories: biomarker, biomarkers, microRNAs, NGS|Tags: , , , , , |

TAmiRNA CEO/CSO Matthias Hackl will attend the RNA Leaders conference in Basel next week to speak about the recent development of reliable miRNA safety biomarkers and their potential to [...]

Comments Off on TAmiRNA at RNA Leaders conference in Basel

Eager to lern more about Sepsis-associated acute kidney injury?

By |April 10th, 2024|Categories: biomarker, biomarkers, microRNA services, microRNAs, microstructure, miND spike ins, NGS, sequencing, smallRNA, Vivomicx|Tags: , , , |

We are pleased to share our latest publication, a collaborative effort with TAmiRNA, titled 'Sepsis-Induced Heterogeneous Transcription of Coagulation- and Inflammation-Associated Genes in Renal Microvasculature,' which has been published in Thrombosis Research. [...]

Exciting news!

By |April 4th, 2024|Categories: biomarker, biomarkers, Illumina NewSeq2000, microRNA services, microRNAs, miND spike ins, NGS, sequencing, smallRNA|Tags: , , , , , , |

We just received the Illumina NextSeq 2000 machine, marking a significant milestone in our journey towards cutting-edge research and innovation. This powerful instrument will drive our NGS services and allow us to [...]

TAmiRNA at RNA Leaders conference in Basel

By |March 5th, 2024|Categories: biomarker, biomarkers, microRNAs, NGS|Tags: , , , , , |

TAmiRNA CEO/CSO Matthias Hackl will attend the RNA Leaders conference in Basel next week to speak about the recent development of reliable miRNA safety biomarkers and their potential to indicate injury of [...]

Comments Off on TAmiRNA at RNA Leaders conference in Basel
Go to Top